Phillips Distributors Ltd. Pharmaceutical Import Profile — Tanzania (DGFT 2022–2026)

Name: Phillips Distributors Ltd. Pharmaceutical Import Records from India — 2 Products, $800.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Phillips Distributors Ltd. — Pharmaceutical Importer Profile (2026) | 2 Products, $800.0K Trade | TransData Nexus

Phillips Distributors Ltd.

Pharmaceutical Importer · Tanzania · Antibiotics Focus · $800.0K Total Trade · DGFT Verified

Phillips Distributors Ltd. is a pharmaceutical importer based in Tanzania with a total trade value of $800.0K across 2 products in 2 therapeutic categories. Based on 16 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Phillips Distributors Ltd. sources from 2 verified Indian suppliers, with Blue Cross Laboratories Private Limited accounting for 99.6% of imports.

Phillips Distributors Ltd. — Import Portfolio & Supplier Network

Phillips Distributors Ltd. import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Phillips Distributors Ltd.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Blue Cross Laboratories Private Limited	$734.5K	58	99.6%
Sun Pharmaceutical Industries Limited	$3.2K	1	0.4%

Phillips Distributors Ltd. sources from 2 verified Indian suppliers across .

What Formulations Does Phillips Distributors Ltd. Import?

Formulation	Value	Ships
Sonaderm GM cream x 10 GM (bulk drug: clobetasol propionate BP 0.05% w/w miconazole nitrate BP 2 % w/w gentamicin	$181.6K	4
Sonaderm GM cream x 10 GM (bulk drug	$100.0K	2
Ekon dt 10 x 10's (bulk drug	$87.6K	2
Womiban tabs x 1's (bulk drug	$72.2K	2
Sonaderm GM cream x 10 GM (bulk drug: clobetasol propionate BP 0.05% w/w miconazole nitrate BP 2 % w/w gentamicin	$50.0K	1
Ekon dt 10 x 10's (bulk drug: cetrizinedihydrochloride BP 10 MG) (62804 Box)	$43.4K	3
Ekon dt 10 x 10's (bulk drug: cetrizinedihydrochloride BP 10 MG) (57746 Box)	$40.6K	1
Womiban tabs x 1's (bulk drug: albendazole USP 400MG) (356928 Box)	$26.9K	1
Womiban tabs x 1's (bulk drug: albendazole USP 400MG) (302400 Box	$22.5K	3
Sonaderm GM cream x 10 GM (bulk drug: clobetasol propionate BP 0.05% w/w miconazole nitrate BP 2 % w/w gentamicin	$18.1K	3
Ekon dt 10 x 10's (bulk drug: cetrizinedihydrochloride BP 10 MG) (22415 Box)	$15.5K	1
Meftal 250 tabs 10 x 1 x 10's (bulk drug: mefenamic acid BP 250MG) (9818 Box)	$12.0K	1
Meftal 250 tabs 10 x 1 x 10's (bulk	$11.6K	2
Meftal 500 tabs 10 x 10's (bulk drug	$9.7K	1
Meftal 500 tabs 10 x 10's (bulk drug: mefenamic acid BP 500MG) (1500 Box)	$7.5K	1

Phillips Distributors Ltd. imports 40 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Gentamicin	Antibiotics	$400.0K	8	0.8%	13
2	Miconazole	Antifungals	$400.0K	8	2.0%	4

Phillips Distributors Ltd. imports 2 pharmaceutical products across 2 categories into Tanzania totaling $800.0K.

Phillips Distributors Ltd. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Phillips Distributors Ltd. is a prominent pharmaceutical importer and distributor based in Dar es Salaam, Tanzania. Established in 1991, the company operates as a subsidiary of Phillips Pharma Group, a leading entity in the importation, marketing, and distribution of pharmaceuticals, medical devices, and diagnostics across Sub-Saharan Africa. Phillips Pharma Group maintains a significant presence in Tanzania, with its headquarters situated at Plot No. 111, Vingunguti Industrial Area, Dar es Salaam. (phillipspharma.group)

As a key player in Tanzania's pharmaceutical supply chain, Phillips Distributors Ltd. serves a diverse clientele, including retail pharmacies, hospitals, non-governmental organizations (NGOs), and various institutions. The company is recognized for its extensive network and efficient distribution channels, ensuring the availability of a wide range of pharmaceutical products throughout the country. Their operations encompass the importation of finished pharmaceutical formulations, such as tablets, capsules, syrups, and injections, primarily sourced from India. This strategic sourcing aligns with the company's commitment to providing high-quality medications to meet the healthcare needs of the Tanzanian population.

2Distribution Network

Phillips Distributors Ltd. operates a robust distribution network within Tanzania, with its central warehouse located at Plot No. 111, Vingunguti Industrial Area, Dar es Salaam. (phillipspharma.group) This strategic location facilitates efficient logistics and timely delivery of pharmaceutical products to various regions across the country. The company's distribution capabilities are enhanced by its affiliation with Phillips Pharma Group, which has established offices and warehouses in multiple Sub-Saharan African countries, including Kenya, Uganda, Rwanda, Zambia, Nigeria, Ghana, Mauritius, and Namibia. (phillipspharma.group)

The extensive network of Phillips Pharma Group enables Phillips Distributors Ltd. to leverage regional logistics infrastructure, ensuring a steady supply of pharmaceutical products to meet the demands of the Tanzanian market. This interconnected distribution system underscores the company's commitment to maintaining a resilient and responsive supply chain, capable of addressing the diverse healthcare needs of the population.

3Industry Role

Phillips Distributors Ltd. plays a pivotal role in Tanzania's pharmaceutical supply chain as a primary wholesaler and distributor. By importing finished pharmaceutical formulations from reputable manufacturers, particularly in India, the company ensures the availability of essential medications across the country. Their operations encompass the entire distribution process, from importation to delivery, serving a wide range of clients, including retail pharmacies, hospitals, NGOs, and other institutions. This comprehensive approach positions Phillips Distributors Ltd. as a central figure in the Tanzanian pharmaceutical sector, contributing significantly to the healthcare infrastructure.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Phillips Distributors Ltd.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Phillips Distributors Ltd. demonstrates a high degree of sourcing concentration, with a total import value of $800,000 USD from India over 16 shipments. The company's portfolio is exclusively composed of two products—Gentamicin and Miconazole—each accounting for 50% of the total import value. This singular focus on two products suggests a strategic decision to specialize in these therapeutic areas, potentially leveraging established relationships with suppliers and ensuring consistent product quality.

The dominance of a single supplier, BLUE CROSS LABORATORIES PRIVATE LIMITED, which accounts for 99.6% of the total import value, indicates a strong and stable partnership. However, this reliance also exposes Phillips Distributors Ltd. to risks associated with supplier dependency, such as potential supply chain disruptions or changes in supplier terms. To mitigate these risks, the company may consider diversifying its supplier base or establishing contingency plans to maintain a steady supply of critical pharmaceutical products.

2Supply Chain Resilience

The resilience of Phillips Distributors Ltd.'s supply chain is closely tied to its sourcing strategy from India, particularly its reliance on BLUE CROSS LABORATORIES PRIVATE LIMITED for the majority of its imports. While this supplier relationship offers stability, it also presents challenges in terms of supply chain diversification. The company's focus on two specific products—Gentamicin and Miconazole—limits its product diversification, which could be a strategic choice to concentrate on high-demand medications.

Importing Pharmaceuticals into Tanzania — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Tanzania

1Regulatory Authority & Framework

The Tanzania Medicines and Medical Devices Authority (TMDA) is the primary regulatory body overseeing the importation and exportation of pharmaceutical products in Tanzania. Established under the Tanzania Medicines and Medical Devices Act Cap. 219, TMDA is responsible for ensuring the safety, efficacy, and quality of medicines and medical devices entering the Tanzanian market. (tmda.go.tz)

Key legislation governing pharmaceutical imports includes the Tanzania Medicines and Medical Devices Act Cap. 219 and the associated regulations, which outline the requirements for importers, the process for obtaining import permits, and the standards for pharmaceutical products. The Act mandates that all pharmaceutical products imported into Tanzania must be registered with TMDA, ensuring that only approved and safe medications are available to the public. (tmda.go.tz)

2Import Licensing & GMP

Importers of pharmaceutical products in Tanzania must obtain an import permit from TMDA before bringing products into the country. The application process involves registering the importer's premises with TMDA and submitting an application through the online trader portal. Applications should be lodged at least six weeks prior to the expected arrival of the consignment to avoid storage costs at ports of entry and potential disposal of unpermitted products. (tmda.go.tz)

Phillips Distributors Ltd. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Phillips Distributors Ltd.'s focus on importing Gentamicin and Miconazole indicates a strategic emphasis on antibiotics and antifungals, therapeutic areas critical to addressing infectious diseases prevalent in Tanzania. The decision to import these specific products aligns with the company's commitment to meeting the healthcare needs of the population by providing essential medications. Market demand for these drugs is driven by the high incidence of bacterial and fungal infections, necessitating a reliable supply of effective treatments.

By concentrating on these therapeutic categories, Phillips Distributors Ltd. can leverage its expertise and established supplier relationships to ensure consistent product availability and quality. This strategic focus also allows the company to build strong partnerships with healthcare providers and institutions that rely on these medications, thereby enhancing its position in the Tanzanian pharmaceutical market.

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Phillips Distributors Ltd.

What products does Phillips Distributors Ltd. import from India?

Phillips Distributors Ltd. imports 2 pharmaceutical products across 2 categories. Top imports: Gentamicin ($400.0K), Miconazole ($400.0K).

Who supplies pharmaceuticals to Phillips Distributors Ltd. from India?

Phillips Distributors Ltd. sources from 2 verified Indian suppliers. The primary supplier is Blue Cross Laboratories Private Limited (99.6% of imports, $734.5K).

What is Phillips Distributors Ltd.'s total pharmaceutical import value?

Phillips Distributors Ltd.'s total pharmaceutical import value from India is $800.0K, based on 16 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Phillips Distributors Ltd. focus on?

Phillips Distributors Ltd. imports across 2 categories. The largest: Antibiotics (50.0%), Antifungals (50.0%).

Get Full Phillips Distributors Ltd. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.